Histone deacetylase inhibitors regulate P-gp expression in colorectal cancer via transcriptional activation and mRNA stabilization
Metrics: PDF 2456 views | HTML 1851 views | ?
Hao Wang1, Cheng Huang2, Liang Zhao1, Huan Zhang3, Jing Mo Yang4, Peng Luo1, Bing-Xiang Zhan1, Qing Pan1, Jun Li2, Bao-Long Wang1
1Department of Clinical Laboratory, Affiliated Provincial Hospital of Anhui Medical University, Hefei, China
2School of Pharmacy, Anhui Medical University, Hefei, China
3Department of Biochemistry and Molecular Biology, Sichuan Cancer Hospital and Institute, Chengdu, China
4Department of Pharmacy, Anhui Provincial Cancer Hospital (West Branch of Anhui Provincial Hospital), Hefei, China
Bao-Long Wang, email: [email protected]
Jun Li, email: [email protected]
Keywords: histone deacetylase inhibitors, P-gp, STAT3, stability, multidrug resistance
Received: December 23, 2015 Accepted: June 12, 2016 Published: July 08, 2016
Histone deacetylase inhibitors (HDACIs) are emerging as a novel class of anti-tumor drugs. But the effect of HDACIs in tumors treatment has been disappointing, which mainly due to the acquisition of resistance to HDACIs. However, the underlying mechanisms have not been clearly understood. In this study, it was found that HDACIs SAHA and TSA increased P-gp expression in CRC cells, which has been well known to contribute to drug resistant. The mechanisms underlying these effects were investigated. We showed that HDACIs enhanced transcriptional activity of P-gp protein encoding gene ABCB1. HDACIs treatment also increased the protein and mRNA expression of STAT3, but not PXR, CAR, Foxo3a or β-catenin, which are known to be involved in ABCB transcription regulation. Interestingly, knockdown of STAT3 significantly attenuated HDACIs-induced P-gp up-regulation in colorectal cancer cells, suggesting that STAT3 plays a crucial role in HDACIs-up-regulated P-gp. Furthermore, this study revealed for the first time that HDACIs enhanced the stability of ABCB1 at post-transcriptional level. Taken together, these results proved that HDACIs induced P-gp expression by two distinct ways, transcriptional activation and mRNA stabilization. Our results suggested that more attention should be paid to the cancer treatment using HDACIs since they will induce multidrug resistance in cancer cells.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.